MRI may predict adverse tissue reaction in metal-on-metal hip replacement patients

Magnetic Resonance Imaging (MRI) can detect a failing, or potentially failing, metal-on-metal hip implant (MoM) early on, according to a new study presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Early detection can result in timely revision surgery, decreasing the risk for further tissue damage and pain.

Researchers reviewed the of 70 patients who ultimately underwent revision surgery for a failed MoM implant. The images were assessed for the presence of tissue damage, swelling and other characteristics.

The study found that an MRI is highly sensitive and specific to identifying tissue damage in MoM total hip replacement (THR) patients. Early identification of at- can result in timely revision surgery, when necessary, decreasing pain and future damage to surrounding hip tissue.

Also today at the 2013 AAOS Annual meeting, the educational session "Optimizing Management of Patients with Metal-on-metal Hips," featured seven orthopaedic experts discussing the identification and treatment of MoM hip failure.

In December 2012, the Academy issued an Information Statement on Metal-on-metal Hip Arthroplasty (replacement) recommending a "low threshold" for commencing the evaluation of a patient with an MoM hip replacement, as "early recognition and diagnosis will facilitate the initiation of appropriate treatment prior to significant adverse biological reactions." The statement also provides a detailed overview of various diagnostic and treatment methods to limit patient discomfort, and outlines when to quickly initiate treatment, and if necessary revision.

add to favorites email to friend print save as pdf

Related Stories

You have your MoM's ions

Mar 09, 2010

Hip replacement patients with metal-on-metal (MoM) implants (both the socket and hip ball are metal) pass metal ions to their infants during pregnancy, according to a new study presented today at the 2010 Annual Meeting of ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.